Autologous skin minigraft and ingestion of 8-methoxipsoralen in patients with vitiligo vulgaris;Mini injerto autólogo de piel e ingestión de 8-metoxipsoraleno en pacientes con vitiligo vulgar estable

Dermatologia Revista Mexicana

Volumn 46, Issue 6, 2002, Pages 260-267

  Jiménez, Rodolfo Navarro ^a,c   Aguirre, Alejandro Canales ^b   Ponce, Hugo Salado ^b   Velasco, Alfredo Feria ^b  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^b CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

^c NONE   (Mexico)

Author keywords

8 methoxipsoralen; Autologous skin minigraft; Melanocytes; Pearson r correlation; Placebo; Tukey Kramer multiple comparisons test; Vitiligo vulgaris

Indexed keywords

METHOXSALEN; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; MALE; MELANOCYTE; RANDOMIZED CONTROLLED TRIAL; SKIN GRAFT; SKIN PIGMENTATION; TREATMENT DURATION; TREATMENT RESPONSE; VITILIGO;

EID: 35348926771     PISSN: 01854038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. a ed. Buenos Aires: Médica Panamericana; 1997:626-82.
2. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998;134:1543-9.
3. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-66.
4. Ortone JP. Dyschromies. Encycl Med Chir. Paris Dermatol 1978; 12280 A10:1-17.
5. Fitzpatrick TB, Jonson RA, Polano MK, Surmond D, Wolf K. Atlas de dermatología clínica. México: Interamericana-McGraw-Hill, 1996; 630-5.
6. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N. The role of tyrosinase in autoimmune vitiligo. Lancet 1994;344:1049-52.
7. Buxton PK. ABC de la dermatología. México: BMJ Latinoamérica, 1998:105.
8. Hyrcek A, Szwed Z, Badowski R. Rarely encountered association of hyperthyroidism in the form of Graves-Basedow disease with vitiligo. Wiad Leck 1994;47:213-5.
9. Saban J, Rodríguez-Garcia JL, Gil J, Pais JR, Medina S. Porphiria cutanea tarda associated with autoimmune hypothyroidism, vitiligo and alopecia universalis. Neth J Med 1991;39:350-2.
10. Boisseau-Gargaud AM, Vezon G, Helenon R, Garsaud P, Saint-Cyr I, Quist D. High prevalence of vitiligo in lepromatous leprosy. Int Dermatol 2000;39:837-9.
11. Liu PY, Bondensson L, Lontz W, Johanson O. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: A case-control study. Arch Dermatol Res 1996;288:670-5.
12. Sanchez CI, Espana AA. Role of neuropeptides in dermatology. Rev Neurol 1997;3:222-31.
13. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Brit J Dermatol 1994;131:160-5.
14. Lazarova R, Hristakieva E, Lazarov N, Shani J. Vitiligo-related neuropeptides in nerves fibers of skin. Arch Physiol Biochem 2000;108:262-7.
15. Goldstein E, Haberman HF, Menon JA, Pawlowski D. Non psoralen treatment of vitiligo. Part I. Cosmetics systemic coloring agents and corticosteroids. Int J Dermatol 1992;31:229-36.
16. Jimbow K. Vitiligo. Therapeutic advances. Dermatol Clin 1998;6:399-407.
17. Du Vivier A. Atlas de dermatología clínica. Cap. 23. México: OTC, 1989:1-10.
18. Westerhof W, Nieuweboer-Krotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-8.
19. Andreassi L, Piagnigani E, Andreassi A, Taddeucci P, Biagioli M. A new model of epidermal cultured for the surgical treatment of vitiligo. Int J Dermatol 1998;36:595-8.
20. Kumagai N, Uchikoshi T. Treatment of extensive hypomelanosis with autologous cultured epithelium. Ann Plast Surg 1997;39:68-73.
21. Kaufmann R, Greiner D, Kippenberger S, Bernd A. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm Venereol 1998;78:136-8.
22. Billingham RE, Silvers WK. Studies on the migratory behavior of melanocytes in guinea pig skin. J Exp Med 1970;131:101-7.
23. Boersma BR, Westerhof W, Bos JD. Repigmentation in vitiligo vulgaris by autologous minigrafting: Results in nineteen patients. J Am Acad Dermatol 1995;33:990-5.
24. Schwartzman-Solon AM, Sousa FL, Arroyo CE. Tratamento do vitiligo a través de minienxertos. Med Cutan Ibero Lat Am 1994;22:127-31.
25. Koga M. Epidermal grafting using the top of suction blisters in the treatment of vitiligo. Arch Dermatol 1988;124:1656-8.
26. Tawade YV, Gokhale BB, Parakh A. Autologous graft by suction blister technique in management of vitiligo. Indian J Dermatol Veneorol Lepr 1991;57:91-3.
27. Kahn AM, Cohen MJ. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin graft. Dermatol Surg 1998;24:365-7.
28. Agrawal K, Agrawal A. Vitiligo: Repigmentation with dermabrasion and thin splint-thickness skin graft. Dermatol Surg 1995;21:295-300.
29. Suga Y, Butt KI, Takimoto R, Fujioka N, Yamada H, Ogawa H. Successful treatment of vitiligo with PUVA-pigmented autologous epidermal grafting. Int J Dermatol 1996;35:518-22.
30. Hann SK, Im S, Bong HW, Par YH. Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J Am Acad Dermatol 1995;32:943-8.
31. Gómez BM, Fernández RC, Harto CA. PUVA. Terapia tópica. Piel 1993;8:359-63.
32. Lee AY, Jang JH. Autologous epidermal grafting with PUVA irradiated donor skin for the treatment of vitiligo. Int J Dermatol 1998;37:551-4.
33. Woodley DT, O'keefe EJ, Pruneiras M. Cutaneous wound healing: A model for cell-matrix interactions. J Am Acad Dermatol 1985;12:420-33.